David-Alexandre C. Gros

2015 - Alnylam Pharmaceuticals

In 2015, David-Alexandre C. Gros earned a total compensation of $10.2M as Senior Vice President, Chief Business Officer at Alnylam Pharmaceuticals.

Compensation breakdown

Bonus$200,000
Non-Equity Incentive Plan$95,819
Option Awards$9,630,797
Salary$241,106
Other$508
Total$10,168,230

Gros received $9.6M in option awards, accounting for 95% of the total pay in 2015.

Gros also received $200K in bonus, $95.8K in non-equity incentive plan, $241.1K in salary and $508 in other compensation.

Rankings

In 2015, David-Alexandre C. Gros' compensation ranked 487th out of 13,638 executives tracked by ExecPay. In other words, Gros earned more than 96.4% of executives.

ClassificationRankingPercentile
All
487
out of 13,638
96th
Division
Manufacturing
162
out of 5,187
97th
Major group
Chemicals And Allied Products
64
out of 1,857
97th
Industry group
Drugs
51
out of 1,531
97th
Industry
Pharmaceutical Preparations
40
out of 1,179
97th
Source: SEC filing on March 17, 2016.

Gros' colleagues

We found four more compensation records of executives who worked with David-Alexandre C. Gros at Alnylam Pharmaceuticals in 2015.

2015

John Maraganore

Alnylam Pharmaceuticals

Chief Executive Officer

2015

Barry Greene

Alnylam Pharmaceuticals

Chief Operating Officer

2015

Akshay Vaishnaw

Alnylam Pharmaceuticals

Chief Medical Officer

2015

Michael Mason

Alnylam Pharmaceuticals

Vice President of Finance and Treasurer principal financial officer

News

In-depth

You may also like